Centre for Rural Health, University of Aberdeen, Old Perth Road, Inverness, IV2 3JH, UK.
Department of Stroke and Rehabilitation, Raigmore Hospital, NHS Highland, Inverness, IV2 3UJ, UK.
BMC Emerg Med. 2019 Sep 4;19(1):49. doi: 10.1186/s12873-019-0262-1.
Recanalisation therapy in acute ischaemic stroke is highly time-sensitive, and requires early identification of eligible patients to ensure better outcomes. Thus, a number of clinical assessment tools have been developed and this review examines their diagnostic capabilities.
Diagnostic performance of currently available clinical tools for identification of acute ischaemic and haemorrhagic strokes and stroke mimicking conditions was reviewed. A systematic search of the literature published in 2015-2018 was conducted using PubMed, EMBASE, Scopus and The Cochrane Library. Prehospital and in-hospital studies with a minimum sample size of 300 patients reporting diagnostic accuracy were selected.
Twenty-five articles were included. Cortical signs (gaze deviation, aphasia and neglect) were shown to be significant indicators of large vessel occlusion (LVO). Sensitivity values for selecting subjects with LVO ranged from 23 to 99% whereas specificity was 24 to 97%. Clinical tools, such as FAST-ED, NIHSS, and RACE incorporating cortical signs as well as motor dysfunction demonstrated the best diagnostic accuracy. Tools for identification of stroke mimics showed sensitivity varying from 44 to 91%, and specificity of 27 to 98% with the best diagnostic performance demonstrated by FABS (90% sensitivity, 91% specificity). Hypertension and younger age predicted intracerebral haemorrhage whereas history of atrial fibrillation and diabetes were associated with ischaemia. There was a variation in approach used to establish the definitive diagnosis. Blinding of the index test assessment was not specified in about 50% of included studies.
A wide range of clinical assessment tools for selecting subjects with acute stroke has been developed in recent years. Assessment of both cortical and motor function using RACE, FAST-ED and NIHSS showed the best diagnostic accuracy values for selecting subjects with LVO. There were limited data on clinical tools that can be used to differentiate between acute ischaemia and haemorrhage. Diagnostic accuracy appeared to be modest for distinguishing between acute stroke and stroke mimics with optimal diagnostic performance demonstrated by the FABS tool. Further prehospital research is required to improve the diagnostic utility of clinical assessments with possible application of a two-step clinical assessment or involvement of simple brain imaging, such as transcranial ultrasonography.
急性缺血性脑卒中的再通治疗非常注重时间,需要早期识别符合条件的患者,以确保更好的疗效。因此,已经开发了许多临床评估工具,本综述检查了它们的诊断能力。
综述了目前用于识别急性缺血性和出血性卒中和卒中模拟病症的临床工具的诊断性能。使用 PubMed、EMBASE、Scopus 和 The Cochrane Library 对 2015 年至 2018 年发表的文献进行了系统检索。选择了至少有 300 名患者样本量的预住院和住院研究报告诊断准确性。
共纳入 25 篇文章。皮质体征(眼球运动障碍、失语症和忽视)被证明是大血管闭塞(LVO)的重要指标。用于选择 LVO 患者的敏感性值范围为 23%至 99%,特异性为 24%至 97%。包含皮质体征以及运动功能障碍的临床工具,如 FAST-ED、NIHSS 和 RACE,表现出最佳的诊断准确性。用于识别卒中模拟的工具的敏感性范围为 44%至 91%,特异性为 27%至 98%,其中 FABS(90%的敏感性,91%的特异性)表现出最佳的诊断性能。高血压和年龄较小预测颅内出血,而心房颤动和糖尿病的病史与缺血有关。确定明确诊断的方法存在差异。约 50%的纳入研究未明确说明对指数测试评估的盲法。
近年来,已经开发了许多用于选择急性脑卒中患者的临床评估工具。使用 RACE、FAST-ED 和 NIHSS 评估皮质和运动功能,显示出选择 LVO 患者的最佳诊断准确性值。用于区分急性缺血和出血的临床工具的数据有限。用于区分急性卒中和卒中模拟的诊断准确性似乎较为适中,FABS 工具的最佳诊断性能。需要进一步进行院前研究,以提高临床评估的诊断效用,可能需要应用两步临床评估或简单脑成像的参与,如经颅超声检查。